
MassMutual Ventures co-led the healthcare data platform developer's series B round, which also featured Aviva Ventures and Jianke.
William Taranto spoke about his near decade at Merck Global Health Innovation Fund and how corporate venturing has evolved in that time.
Medtronic, LivaNova and Baxter Healthcare have helped commit $53.5m for the third medical device-based fund to be raised under the MD Start moniker.
Alphabet, Novartis and Johnson & Johnson have contributed to a series C round for Cala Health, which is preparing to release its wearable hand-tremor treatment device.
Susquehanna International Group has led a series B round for elderly healthcare services provider Shanzhen that was in the eight-figure dollar range.
The drug development software provider has added $25m to an Alphabet and Wuxi AppTech-backed first tranche it closed in January.
Lundbeckfond Ventures contributed to a round that will fund clinical trials for Reneo Pharmaceuticals' mitochondrial disease therapies.
OSF Healthcare Ventures was among the participants in an extension to the cancer testing technology provider's series B round, which has now reached $15m.
SinoUnited secured $14.4m and the Kuok Group-backed round will support the hiring of more doctors and the opening of additional healthcare centres.
M Ventures, Pfizer Ventures and Taiho Ventures all returned to help boost cancer drug developer Storm Therapeutics' series A round to $38.2m.